Leaderboard

En | De
Sie sind hier: Hämatologie » Neoplasie 30. April 2026
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Anämie
Gerinnungsstörungen
Neoplasie
Anderes
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 8369  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 167363  
   
Nontranslocation follicular lymphoma mimicking infectious mononucleosis: a diagnostic challenge in a 39-year-old male.
Oxf Med Case Reports
Barsh E, Keeling J, Pang CS, Sattler R, Feustel K, Enurah A.
PMID: 42057973 [PubMed]


CXCR4-targeted PET/CT with [¹â¸F]AlF-NOTA-QHY-04 in primary central nervous system lymphoma: a prospective comparison with MRI and [¹â¸F]FDG PET/CT.
Eur J Nucl Med Mol Imaging
Pang Y, Xing L, Liu J, Zhao X, Li C, Xu S, Pei J, Yu J, Chen H, Liu J.
PMID: 42056569 [PubMed - as supplied by publisher]


Predicting survival of Hodgkin lymphoma using machine learning-an analysis based on the SEER database.
Ann Hematol
Cai X, Kang L.
PMID: 42056487 [PubMed - indexed for MEDLINE]


Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): A practical compartment-based review.
Blood Rev
Mozas P, Combalia A, Antelo G, López-Oreja I, Castrejón de Anta N, Monge-Escartín I, Moreno-Alonso D, Gil-Lianes J, Juncosa M, Salas MQ, Charry P, Albero R, García-Herrera A, López Guillermo A, Estrach T.
PMID: 42055866 [PubMed - as supplied by publisher]


HSR26-228: BTK Inhibitor (Bruton Tyrosine Kinase Inhibitor) Plus Anti-CD20 Antibody Therapy Surpasses CIT (Chemoimmunotherapy) in Frontline CLL (Chronic Lymphocytic Leukemia) With Obinutuzumab Drives Deeper Remissions: A Meta-Analysis of Randomized Controlled Trials.
J Natl Compr Canc Netw
Sharma A, Daid SS, Sharma A, Meseeha M, Poulose J.
PMID: 42055453 [PubMed - in process]


CLO26-106: From Vasculitis to NK/T-Cell Lymphoma: A Complex Diagnosis in a Patient With a Midline Tumor and Positive ANCA.
J Natl Compr Canc Netw
Hernández I, Vargas LP, León JMM, Ballesteros-García MC, Bacca J, Ferro JD, Dorado L, Santoyo-Sarmiento N.
PMID: 42055427 [PubMed - in process]


EPR26-321: Sorafenib Plus Intensive Chemotherapy in Newly Diagnosed Adults With Acute Myeloid Leukemia: A Meta-Analysis of Randomized Controlled Trials.
J Natl Compr Canc Netw
Vatvani AD, Nada R, Altamirano MFA, Damara I, Oktrian O, Yausep OE, Shabarek N.
PMID: 42055402 [PubMed - in process]


HSR26-241: Prophylactic G-CSF (Granulocyte Colony-Stimulating Factor) in AML (Acute Myeloid Leukemia) Induction: A Meta-Analysis Dispelling Relapse Concerns and Reinforcing Supportive Benefit.
J Natl Compr Canc Netw
Sharma A, Sharma A, Daid SS, Meseeha M, Poulose J.
PMID: 42055401 [PubMed - in process]


HSR26-237: Meta-Analysis Confirms Venetoclax Plus Decitabine as a Frontline Game-Changer in Elderly AML (Acute Myeloid Leukemia).
J Natl Compr Canc Netw
Sharma A, Sharma A, Daid SS, Meseeha M, Poulose J.
PMID: 42055035 [PubMed - in process]


Random Survival Forest Versus Elastic-Net Regularized Cox Regression for Survival Prediction in Acute Myeloid Leukemia at Distinct Treatment Time Points: Model Performance Comparison Study.
JMIR Bioinform Biotechnol
Brady O, Johnson S, Giles P, Alvares C, Zabkiewicz J, Fuentes C.
PMID: 42054649 [PubMed]


Integrative Molecular Analysis Reveals Determinants of Clinical Outcomes in TP53-Mutated Diffuse Large B-Cell Lymphoma.
J Clin Oncol
Uppal M, Bhinder B, Marderstein AR, Lee Batlevi C, Falchi L, Hamlin P, Horwitz S, Kumar A, Noy A, Zelenetz AD, Lue JK, Torka P, Epstein-Peterson ZD, Arcila M, Dogan A, Imber B, Yahalom J, Vardhana SA, Intlekofer A, Raj S, Shouval R, Hodkinson B, Stokes ME, Kittai AS, Brody JD, Elemento O, Salles G, Joffe E.
PMID: 42054619 [PubMed - as supplied by publisher]


TP53 genetic alterations are highly recurrent in Epstein-Barr virus-negative aggressive NK-cell leukemia: insights from an institutional experience and comprehensive literature review.
Am J Clin Pathol
Gonzalez Mancera M, Wilk AJ, Oak J, Natkunam Y, Silva O.
PMID: 42054237 [PubMed - indexed for MEDLINE]


CD47: a promising target for immunotherapy in relapsed/refractory malignant lymphoma.
Leuk Lymphoma
Xiong S, Yue N, Zhang S, Xu Y, Cao J, Liu X, Wu C.
PMID: 42054037 [PubMed - as supplied by publisher]


Navigating Prognostic Dialogue During Serious Illness Conversations.
JAMA Netw Open
Borregaard Myrhøj C, Jacobsen J, LeBlanc TW, El-Jawahri A, Jarden M, Clemmensen SN, von Heymann A.
PMID: 42054029 [PubMed - indexed for MEDLINE]


Integrating occupational cancer detection into hospital care? An intervention research to improve blood cancer patient care in France (GISCOPE 84).
Can J Public Health
Hunsmann M, Bertschy S, Amiet É, Aubail A, Bart J, Durand C, Hamdoun F, Rat F, Richier C, Thebaud-Mony A, Zaanane H, Wolf J, Slama B, team of the Hematology-Oncology Department at Avignon Hospital, TheGISCOPE 84 Expert Panel.
PMID: 42053922 [PubMed - indexed for MEDLINE]


Evaluation of DNA methylation-based age prediction accuracy in leukemia patients using a six-CpG model trained on healthy blood.
Forensic Sci Med Pathol
Can K, Filoglu G, Ersoy G, Ozmen D, Eskazan AE, Ar MC, Bulbul O.
PMID: 42053891 [PubMed - as supplied by publisher]


Anti-CD19 chimeric antigen receptor (CAR)-T cell therapy vs. CD20xCD3 bispecific antibody as third- or later-line treatment in follicular lymphoma: a meta-analysis.
Ann Hematol
Li X, Liao J, Liu S, Mo X, Wang B.
PMID: 42053782 [PubMed - in process]


EASIX score is predictive of early fatal complications in newly diagnosed acute myeloid leukemia.
Ann Hematol
Finotto T, Tauveron-Jalenques U, Barrière S, Adelou S, Futier E.
PMID: 42053661 [PubMed - in process]


Age-stratified nomogram development and validation for predicting voriconazole trough concentrations above safety threshold in pediatric patients with hematologic malignancy.
Eur J Clin Pharmacol
An N, Han Y, Jia C, Ding W, Liu J, Zhao Y.
PMID: 42053650 [PubMed - indexed for MEDLINE]


A PET-radiomics diagnostic signature to differentiate Hodgkin lymphoma from aggressive non-Hodgkin lymphomas.
Biomed Tech (Berl)
Huang Y, Zhi T, Miao Y, Meng C.
PMID: 42053243 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 167363    Seite 1 von 8369  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1